See also this year's filing and all EDGAR filings for this company.
PDF Report 0001418133_2017_Biostar_Pharmaceuticals_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001418133, Biostar Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 7,365,124 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 5,607,146 |
| 2 | PropertyPlantAndEquipmentNet | 5,866,612 |
| 3 | remainder_Assets | 23,663,556 |
| 4 | LiabilitiesCurrent | 5,623,261 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 1,469,318 |
| 8 | SellingGeneralAndAdministrativeExpense | 2,431,462 |
| 9 | ResearchAndDevelopmentExpense | 1,144,044 |
| 10 | remainder_Expenses | 3,556,984 |
| 11 | remainder_Revenues | 2,384,492 |
| 12 | remainder_NetIncome | 518,931 |
| 13 | remainder_ComprehensiveNetIncome | -2,753,697 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 42,502,438 |
| 1 | Liabilities | 5,623,261 |
| 2 | Expenses | 8,601,808 |
| 3 | Revenues | 2,384,492 |
| 4 | StockholdersEquity | 36,879,177 |
| 5 | NetIncome | -5,698,385 |
| 6 | ComprehensiveNetIncome | -7,075,234 |
| 7 | BaseVar | 31,192,314 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.05 |
| 9 | EconomicCapitalRatio | 3.72 |
Edgar->Model Mapping
Feature Distribution
Change over Time
